Gilead and Agenus sign cancer drug development deal
Gilead Sciences has partnered with US-based biotechnology company Agenus for the development and commercialisation of...
Big Data and AI will drive innovation, revenue and operational efficiencies in 2019
Healthtech will rise to prominence in 2019 as Big Data and Artificial Intelligence (AI) become...
AstraZeneca announces positive results from SOLO-3 trial of Lynparza
AstraZeneca and its partner Merck have published positive results from SOLO-3 phase III trial of...
Adalimumab biosimilar deal to save the NHS millions
Recently, the National Health Service (NHS) in the UK announced they have completed negotiations over...
Find out about the foundation for the first drugs using microbiome bacteria in the latest issue of Pharma Technology Focus
In this issue: A new class of cancer combo treatments, antidepressants in the environment, microbiome-based...
NICE expands its recommendation for Oncotype Dx test
The UK’s pricing regulator the National Institutes of Health and Care Excellence (NICE) has expanded...
Going digital to improve clinical trial enrolment
Clinical trial enrolment is a long-standing problem for drug developers, so it is hoped that...
GSK and Pfizer to create $13bn consumer healthcare joint venture
GlaxoSmithKline (GSK) and Pfizer have agreed to merge their consumer health businesses to create a...
Characterising Eastern China’s pharmaceutical manufacturing market
China is not only potentially the largest healthcare market in the world, but it is...
Verzenio to be studied in a Phase II trial in AR+ breast cancer patients
Verzenio's Phase II trial should start in early 2019 after funding was approved by sponsor...